-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VKpQBwhHz+ljb0foPG+x+2zSdu9Iyy9gh3FSMQVyyx0aBc0PU9Y8eZtXyeadp32J
 BAlgzcP7xlj/vi47fI4Saw==

<SEC-DOCUMENT>0001181431-10-051413.txt : 20101019
<SEC-HEADER>0001181431-10-051413.hdr.sgml : 20101019
<ACCEPTANCE-DATETIME>20101019173631
ACCESSION NUMBER:		0001181431-10-051413
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20101015
FILED AS OF DATE:		20101019
DATE AS OF CHANGE:		20101019

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SITRICK MICHAEL S
		CENTRAL INDEX KEY:			0001371443

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33657
		FILM NUMBER:		101131193

	MAIL ADDRESS:	
		STREET 1:		11777 SAN VICENTE BLVD SUITE 5500
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90049

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Abraxis BioScience, Inc.
		CENTRAL INDEX KEY:			0001409012
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				300431735
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		11755 WILSHIRE BLVD., 20TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		310-883-1300

	MAIL ADDRESS:	
		STREET 1:		11755 WILSHIRE BLVD., 20TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Abraxis Biosciences, Inc.
		DATE OF NAME CHANGE:	20071120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	New Abraxis, Inc.
		DATE OF NAME CHANGE:	20070806
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd288897.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2010-10-15</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0001409012</issuerCik>
        <issuerName>Abraxis BioScience, Inc.</issuerName>
        <issuerTradingSymbol>ABII</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001371443</rptOwnerCik>
            <rptOwnerName>SITRICK MICHAEL S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ABRAXIS BIOSCIENCE LLC.</rptOwnerStreet1>
            <rptOwnerStreet2>11755 WILSHIRE BOULEVARD, SUITE 2000</rptOwnerStreet2>
            <rptOwnerCity>LOS ANGELES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>90025</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Non-qualified Stock Option</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>38.08</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2010-10-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>D</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>10000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>35.06</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2010-12-10</value>
            </exerciseDate>
            <expirationDate>
                <value>2019-12-10</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>10000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Pursuant to the Agreement and Plan of Merger, dated as of June 30, 2010, among Celgene Corporation (&quot;Celgene&quot;), Artistry Acquisition Corp. (&quot;Merger Sub&quot;) and Abraxis BioScience, Inc. (&quot;Abraxis&quot;), whereby Merger Sub merged into Abraxis, with Abraxis continuing as the surviving company and a wholly owned subsidiary of Celgene (the &quot;Merger&quot;), this option, which was granted, and became exercisable, on December 10, 2009, was cancelled in exchange for (i) a cash payment of $350,600.00, which represents the excess of $73.14 per share over the exercise price per share of this option and (ii) a contingent value right issued by Celgene.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Michael Sitrick</signatureName>
        <signatureDate>2010-10-19</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
